emerging agents in the pipeline for merkel cell carcinoma
Published 7 years ago • 62 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
0:42
dr. kudchadkar on immunotherapy in merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
7:01
fda approvals in ovarian cancer and merkel cell carcinoma
-
3:19
labs in action: a new immunotherapy treatment for merkel cell carcinoma
-
54:34
uncovering merkel cell polyomavirus
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
2:11
using immuno-oncology agents in merkel cell carcinoma
-
10:39
fda approvals in ovarian cancer, merkel cell carcinoma, itp, and more
-
1:08
novel approaches in treating merkel cell carcinoma
-
57:21
clinical utility of a novel assay for tracking tumor burden in merkel cell carcinoma
-
1:43
dr. nghiem on immunotherapy in merkel cell carcinoma
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
1:09
new standard of care for merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
1:53
new treatment approaches for merkel cell carcinoma - checkpoint inhibitors
-
3:09
new insights in merkel cell biology and treatment
-
10:00
priority review in merkel cell carcinoma, breakthrough designation in ret-altered cancers, and more
-
43:44
netwise episode 29: merkel cell carcinoma